Octavalent intranasal flu vaccine proves effective in neutralizing both existing and emerging strains

A new octavalent intranasal vaccine shows promising results in providing broad immunity against both seasonal and pre-pandemic influenza strains by eliciting strong mucosal and systemic immune responses in ferrets.

PRO-1107 by ProfoundBio Suzhou for Solid Tumor: Likelihood of Approval – Pharmaceutical Technology

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 20, 2024

WannaCry Wasn’t Enough: Why Healthcare Still Struggles with Cybersecurity Communication

Mike Walters, President & co-founder of Action1 Corporation According to the HHS Office for Civil Rights (OCR), cyber incidents in health care are on the

July 15, 2024

Study shows how segregated communities face challenges in filling OUD medications

Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.